Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Vertanical’s Phase 3 win for non-opioid painkiller; Apriori lays off 40% of staff
2 months ago
News Briefing
Post-Hoc: Kennedy's anti-vaccine actions shouldn't surprise anyone
2 months ago
Pharma
FDA+
George Church spinout developing genomically recoded organisms cuts most employees
2 months ago
People
Startups
Curevo gets $110M for a shot against Shingrix, gets Moncef Slaoui and Tal Zaks on board
2 months ago
Financing
Startups
Otsuka's Taiho buys Swiss startup Araris with three ADCs nearing the clinic
2 months ago
Startups
Deals
AstraZeneca spotlights first-in-human data for B7-H4-targeting ADC in endometrial cancer
2 months ago
R&D
HC Bioscience, a tRNA biotech backed by ARCH and Takeda, shuts down
2 months ago
People
Startups
Avidity seeks to 'set the standard' as it heads to FDA with Duchenne drug
2 months ago
R&D
Pharma
AstraZeneca to buy cell therapy startup for $425M upfront
2 months ago
Deals
Cell/Gene Tx
Latigo collects $150M to get non-opioid data to compete with Vertex in acute pain
2 months ago
Financing
Startups
Lilly-backed UK biotech raises $72M to advance its antibody approach
2 months ago
Financing
Startups
Updates on health agency nominees; New data from Pfizer, Beam; MASH startup weighs IPO; and more
2 months ago
Weekly
'It’s the law’: Dr. Oz says he would defend Medicare drug price negotiations
2 months ago
Pharma
FDA+
Federal Circuit ruling allows Amgen's Eylea biosimilar to stay on the market
2 months ago
Pharma
Law
Boston Pharma, building off MASH momentum, mulls an IPO ahead of Phase 3 trial
2 months ago
R&D
UK's plan to hike drugmaker rebates reflects 'broken' system, pharma group says
2 months ago
Pharma
Recipharm hits record revenue for 2024, eyes GLP-1 contracts for growth
2 months ago
Pharma
Manufacturing
RFK Jr. convened roundtable around ways to reduce stem cell regulation
2 months ago
Pharma
Cell/Gene Tx
Altimmune to put its incretin into addiction trials; Tarsus aims to raise $125M
2 months ago
News Briefing
Sutro slashes workforce in half, changes CEO and closes factory
2 months ago
People
Pharma
Merck diversity leader to retire this summer; Geron seeks commercial chops for next CEO
2 months ago
Peer Review
Lilly-partnered Fauna Bio plans $40M Series A to get into heart failure
2 months ago
Financing
Startups
MoonLake's CEO on its looming mid-year pivotal readout in skin disease
2 months ago
Pharma
Pfizer terminates an early-stage STING agonist trial
2 months ago
R&D
Pharma
First page
Previous page
23
24
25
26
27
28
29
Next page
Last page